| 臺大學術典藏 |
2022-08-19T00:21:07Z |
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma
|
Hsiao S.-M.; Chen C.-A.; CHIUN HSU; Lin H.-H.; Hsieh C.-Y.; Wei L.-H. |
| 臺大學術典藏 |
2020-02-12T05:48:30Z |
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma
|
Hsiao S.-M; Chen C.-A; Hsu C; Lin H.-H; Hsieh C.-Y; LING-HUNG WEI |
| 臺大學術典藏 |
2020-02-17T08:51:03Z |
Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma
|
Hsiao S.-M; Chen C.-A; Hsu C; HO-HSIUNG LIN; Hsieh C.-Y; Wei L.-H. |
| 臺大學術典藏 |
2022-08-19T00:21:15Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Cheng A.-L.; Wu C.-Y.; Chen J.-S.; Li C.-C.; Liu H.-T.; Hsu C.-H.; Lu Y.-S.; Yeh K.-H.; Yang C.-H.; Shen Y.-C.; CHIUN HSU |
| 臺大學術典藏 |
2018-09-10T04:46:18Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu, C. and Shen, Y.-C. and Yang, C.-H. and Yeh, K.-H. and Lu, Y.-S. and Hsu, C.-H. and Liu, H.-T. and Li, C.-C. and Chen, J.-S. and Wu, C.-Y. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2004 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Chen J.-S.; Wu C.-Y.; Cheng A.-L.; Li C.-C.; Chiun Hsu;Shen Y.-C.;Yang C.-H.;Yeh K.-H.;Lu Y.-S.;Hsu C.-H.;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Chiun Hsu; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T. |
| 臺大學術典藏 |
2004 |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Liu H.-T.; Hsu C.; Hsu C.;Shen Y.-C.;Yang C.-H.;Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Cheng A.-L.; Wu C.-Y.; Li C.-C.; Chen J.-S. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C;Shen Y.-C;Chih-Hsin Yang;Yeh K.-H;Lu Y.-S;Hsu C.-H;Liu H.-T;Li C.-C;Chen J.-S;Wu C.-Y;Cheng A.-L.; Hsu C; Shen Y.-C; CHIH-HSIN YANG; Yeh K.-H; Lu Y.-S; Hsu C.-H; Liu H.-T; Li C.-C; Chen J.-S; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:21Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C.; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-28T01:06:50Z |
Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract
|
Hsu C.;Shen Y.-C.;Yang C.-H.;Kun-Huei Yeh;Lu Y.-S.;Hsu C.-H.;Liu H.-T.;Li C.-C.;Chen J.-S.;Wu C.-Y.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Yang C.-H.; KUN-HUEI YEH; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; Cheng A.-L. |
